ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,097Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1171

$904K Total Retail Price of All Prescriptions

Rank: 55 out of 1171

755 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

4% of this provider’s 12,793 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 767 515 S3 1 8
OMEPRAZOLE 697 552 2 5
SIMVASTATIN 496 438 3 1
LISINOPRIL 488 402 4 3
LEVOTHYROXINE SODIUM 441 395 5 4
METOPROLOL TARTRATE 425 371 6 11
AMLODIPINE BESYLATE 372 316 7 2
ATENOLOL 355 322 8 15
FUROSEMIDE 318 287 9 6
HYDROCHLOROTHIAZIDE 283 260 10 9
TRAMADOL HCL 269 200 11 18
ZOLPIDEM TARTRATE 262 225 12 21
METFORMIN HCL 256 221 13 7
GABAPENTIN 228 148 14 16
WARFARIN SODIUM 220 185 15 12
NEXIUM 187 136 16 25
POTASSIUM CHLORIDE 187 170 16 19
ATORVASTATIN CALCIUM 185 168 18 10
TAMSULOSIN HCL 181 153 19 28
AMITRIPTYLINE HCL 173 117 R 20 74
CARVEDILOL 171 123 21 20
MELOXICAM 163 132 22 56
GLYBURIDE 155 132 R 23 97
PROAIR HFA 138 107 24 49
METFORMIN HCL ER 138 104 24 52
PREDNISONE 134 89 26 39
ISOSORBIDE MONONITRATE ER 132 112 27 44
CHLORTHALIDONE 130 120 28 116
CITALOPRAM HBR 121 104 29 22
CLOPIDOGREL 116 111 30 35
AZITHROMYCIN 115 90 31 43
PLAVIX 114 104 32 55
LOSARTAN POTASSIUM 111 83 33 14
FLUOXETINE HCL 109 91 34 76
CLONIDINE HCL 109 97 34 45
LANSOPRAZOLE 106 97 36 150
ENALAPRIL MALEATE 104 64 37 73
TRAZODONE HCL 103 83 38 37
SYNTHROID 99 81 39 48
METOPROLOL SUCCINATE 94 57 40 17
CARISOPRODOL 92 37 R 41 160
CEPHALEXIN 92 79 41 104
AMOXICILLIN 92 64 41 111
QUINAPRIL HCL 88 81 44 156
HUMALOG 87 64 45 132
DIOVAN 86 86 46 32
PAROXETINE HCL 85 83 47 62
CYMBALTA 85 35 47 64
CIPROFLOXACIN HCL 84 60 49 61
GEMFIBROZIL 82 62 50 117
DILTIAZEM 24HR ER 81 68 51 112
PROPRANOLOL HCL 80 41 52 134
COLCRYS 79 60 53 159
DIGOXIN 78 68 54 68
VERAPAMIL ER 78 76 54 91
OXYCODONE HCL 78 29 S2 54 79
PANTOPRAZOLE SODIUM 77 62 57 29
TRIAMTERENE-HCTZ 75 59 58 58
ADVAIR DISKUS 75 68 58 51
RANITIDINE HCL 75 65 58 38
ALLOPURINOL 72 68 61 31
NABUMETONE 71 55 62 201
FINASTERIDE 70 70 63 88
ENDOCET 69 17 S2 64 161
IBUPROFEN 69 34 64 80
FLUTICASONE PROPIONATE 68 48 66 30
INSULIN SYRINGE 68 36 66 71
SPIRIVA 67 48 68 57
SERTRALINE HCL 63 48 69 23
OXYCODONE-ACETAMINOPHEN 63 25 S2 69 59
SUCRALFATE 62 54 71 182
AGGRENOX 62 62 71 148
DILTIAZEM 24HR CD 61 59 73 101
FENTANYL 61 37 S2 73 89
RAMIPRIL 60 60 75 85
LANTUS 59 45 76 46
PROMETHAZINE HCL 59 29 R 76 87
HYDROXYZINE PAMOATE 58 40 R 78 259
PRAVASTATIN SODIUM 57 48 79 13
HUMULIN N 57 57 79 190
DOXAZOSIN MESYLATE 56 56 81 82
ROPINIROLE HCL 56 51 81 119
OXYCODONE HCL-ACETAMINOPHEN 52 24 S2 83 99
LOVASTATIN 50 42 84 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.